More
    Guided Solutions - Connecting Talent With Innovation/div>

    WISE Completes New Financing Round to Accelerate Development of Heron® Lead

    The Heron® lead is the first unidirectional multicolumn lead for spinal cord stimulation that can be implanted percutaneously for chronic pain treatment. • The new financing round, worth...

    Sutter Health to deploy Flosonics Medical’s Doppler ultrasound device

    US-based integrated healthcare system Sutter Health is set to implement Flosonics Medical’s wireless, wearable Doppler ultrasound device, FloPatch, to enhance the safety of intensive...

    Signati Medical completes enrolment in trial of Separo device

    Signati Medical has completed enrolment in its first-in-human clinical trial for the sealed vasectomy procedure using the Separo Vessel Sealing System. The Signati Separo device...

    Ypsomed sells pen needle, blood glucose monitor business to focus on insulin pump

    Ypsomed announced today that it agreed to sell its pen needle and blood glucose monitoring (BGM) businesses to Medical Technology and Devices (MTD). With the...

    SpineX eyes FDA submission as neurogenic bladder trial hits milestone

    SpineX has closed recruitment for a clinical study investigating its neuromodulation device to treat urinary incontinence. Data from the trial, which began in May 2022,...

    FDA grants IDE to RTI Surgical for breast reconstruction device trial

    The US Food and Drug Administration (FDA) has granted investigational device exemption (IDE) to RTI Surgical’s allograft dermis, opening the door for a clinical...

    Microplate Dx raises £2.5m to develop rapid antibiotic test

    Glasgow-based diagnostics spinout Microplate Dx has raised £2.5m ($3.1m) in seed funding to develop a point-of-care device to identify effective antibiotics for bacterial infections. The...

    Envivo’s smart capsule opens a window on gut health

    Want to know what’s going on across the length of your gastrointestinal tract? Swallowing a smart capsule device developed by Envivo Bio could give...

    SolasCure announces final closing of GBP 10.9m (c. USD 13.3m) Series B fundraise to advance wound care innovation

    SOLASCURE Ltd (SolasCure), a biotechnology company developing a hydrogel containing a recombinant enzyme derived from maggots which aims to accelerate wound debridement, has announced...

    Latest articles